ACR 5.80% 6.5¢ acrux limited

More broadly, the fuss over testosterone seems to have run its...

  1. 116 Posts.
    lightbulb Created with Sketch. 10
    More broadly, the fuss over testosterone seems to have run its course, the outcome being that there was no reason for concern. It's possible that there will be a rebound in sales as a consequence (anyone know when the figurres are duee out?), and perhaps also a decline in the misleading and indeed fraudulent attempts by law firms to drum up business in the form of law suits. Here's hoping.
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.